Skip to main content
Infectious Diseases and Therapy logoLink to Infectious Diseases and Therapy
. 2022 Apr 18;11(3):1313. doi: 10.1007/s40121-022-00634-8

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

Iris De Ryck 1,, Eleanna Sarakinou 2, Usman Nakakana 2, Giulia Luna Cilio 1, Augustin Ndiaye 3, Venanzio Vella 1, Joachim Auerbach 2,5, Juan-Paolo Granada 4, Valentino Conti 2, Audino Podda 2
PMCID: PMC9124245  PMID: 35435576

Correction to: Infect Dis Ther (2022) 11:757–770 10.1007/s40121-022-00596-x

In the original publication of the article, the copyright line was incorrectly published, the correct copyright line should be: GlaxoSmithKline Biologicals S.A.

This has been corrected in this paper.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Infectious Diseases and Therapy are provided here courtesy of Springer

RESOURCES